Scientists at the Technische Universität Dresden/Germany are significantly involved in a European research project entitled “BioSim“ which aims at utilising biosimulation as a new tool in drug development. The use of computer simulations will provide more objective data which helps to develop drug compounds more effectively and to reduce investment in drug development drastically. Above all the number of animal tests as well as clinical studies with volunteers will decrease substantially.
“We intend to translate the existing knowledge of drug metabolism and the operating modes of several organs into mathematical models. These serve to perform complex computer simulations of the involved biochemical processes”, says assistant professor Dr Martin Bertau, biochemist at the Department of Chemistry and Food Chemistry at the Technische Universität Dresden.
The highly ambitious scientific “Network of excellence“ – also called “BioSim” – has been funded with 10.7 million euros by the European Union for a five year period since December 2004 and brings together internationally leading European research groups in the fields of life sciences, medicine and mathematics. The activities are coordinated by Professor Erik Mosekilde, Institute of Physics at the Danish University of Technology in Kgs. Lyngby. On the part of the pharmaceutical industry Apogepha Arzneimittel GmbH is involved in Dresden. The network is completed by European regulatory agencies as well as the European Federation of Pharmaceutical Sciences.
PD Dr Martin Bertau | alfa
More genes are active in high-performance maize
19.01.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn
How plants see light
19.01.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau
On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.
We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...
What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...
For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.
Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...
At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.
No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...
Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.
Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
19.01.2018 | Materials Sciences
19.01.2018 | Health and Medicine
19.01.2018 | Physics and Astronomy